Wellgistics Health files 8-K covering debt arrangement
The Nasdaq-listed wholesaler filed a Form 8-K on September 16, 2026, disclosing debt-related items including new obligations.
Wellgistics Health, Inc., a Delaware-incorporated wholesale drug distributor trading on Nasdaq under ticker WGRX, filed a Form 8-K on September 16, 2026.[1][2]
The filing carries accession number 0001493152-26-042951 and covers a period ending September 11, 2026.[1]
The 8-K reports under Item 1.01 entry into a material agreement, Item 2.03 creation of a direct financial obligation, Item 3.02 unregistered sales of equity securities, Item 7.01, and Item 9.01.[1]
A prior related record was no longer available as of September 13, 2026.[3]